// App-Quantinova.ai

5173 : Role of Gli2 in mediating the progression of prostate cancer to CRPC

Researchers

Presenter

  • Lu Xia

Principal Investigators

  • Tai Qin

  • Luzhe Sun

Medical Centers

  • UTHSCSA, San Antonio, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • Regenerating Family Member 3 Alpha

Drug/Treatment

  • Doxycycline

  • Androgen Tear

  • Bicalutamide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved